Is it possible to develop a 'universal' influenza vaccine?
Identifieur interne : 000129 ( Pmc/Checkpoint ); précédent : 000128; suivant : 000130Is it possible to develop a 'universal' influenza vaccine?
Auteurs : James E. CroweSource :
- Cold Spring Harbor perspectives in biology [ 1943-0264 ] ; 2018.
Abstract
Development of optimal vaccines for influenza is challenging, in part due to the high antigenic variability in field strains associated with genetic shift from reassortment and genetic drift from point mutations. Discovery of conserved antigenic sites on the hemagglutinin (HA) protein for neutralizing antibodies suggested the possibility that influenza vaccines could be developed that induce focused antibody responses to the conserved neutralizing determinants, especially the HA stem region. Recent studies have focused on the antigenicity and immunogenicity of such domains, using monoclonal antibodies and candidate engineered HA stem-based vaccines. Much progress has been made, but we still do not fully understand the biology of the immune response to this unique antigenic region.
Url:
DOI: 10.1101/cshperspect.a029496
PubMed: 28663208
PubMed Central: 5829045
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
PMC:5829045Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Is it possible to develop a 'universal' influenza vaccine?</title><author><name sortKey="Crowe, James E" sort="Crowe, James E" uniqKey="Crowe J" first="James E." last="Crowe">James E. Crowe</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">28663208</idno><idno type="pmc">5829045</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829045</idno><idno type="RBID">PMC:5829045</idno><idno type="doi">10.1101/cshperspect.a029496</idno><date when="2018">2018</date><idno type="wicri:Area/Pmc/Corpus">000827</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000827</idno><idno type="wicri:Area/Pmc/Curation">000827</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000827</idno><idno type="wicri:Area/Pmc/Checkpoint">000129</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000129</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Is it possible to develop a 'universal' influenza vaccine?</title><author><name sortKey="Crowe, James E" sort="Crowe, James E" uniqKey="Crowe J" first="James E." last="Crowe">James E. Crowe</name></author></analytic><series><title level="j">Cold Spring Harbor perspectives in biology</title><idno type="eISSN">1943-0264</idno><imprint><date when="2018">2018</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p id="P1">Development of optimal vaccines for influenza is challenging, in part due to the high antigenic variability in field strains associated with genetic shift from reassortment and genetic drift from point mutations. Discovery of conserved antigenic sites on the hemagglutinin (HA) protein for neutralizing antibodies suggested the possibility that influenza vaccines could be developed that induce focused antibody responses to the conserved neutralizing determinants, especially the HA stem region. Recent studies have focused on the antigenicity and immunogenicity of such domains, using monoclonal antibodies and candidate engineered HA stem-based vaccines. Much progress has been made, but we still do not fully understand the biology of the immune response to this unique antigenic region.</p></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">101513680</journal-id><journal-id journal-id-type="pubmed-jr-id">36409</journal-id><journal-id journal-id-type="nlm-ta">Cold Spring Harb Perspect Biol</journal-id><journal-id journal-id-type="iso-abbrev">Cold Spring Harb Perspect Biol</journal-id><journal-title-group><journal-title>Cold Spring Harbor perspectives in biology</journal-title></journal-title-group><issn pub-type="epub">1943-0264</issn></journal-meta><article-meta><article-id pub-id-type="pmid">28663208</article-id><article-id pub-id-type="pmc">5829045</article-id><article-id pub-id-type="doi">10.1101/cshperspect.a029496</article-id><article-id pub-id-type="manuscript">NIHMS944929</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Is it possible to develop a 'universal' influenza vaccine?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Crowe</surname><given-names>James E.</given-names><suffix>Jr</suffix></name><degrees>MD</degrees><email>james.crowe@vanderbilt.edu</email><aff id="A1">Vanderbilt Vaccine Center, Vanderbilt University Medical Center, 11475 MRB IV, 2213 Garland Avenue, Nashville, TN 37232-0417, Telephone (615) 343-8064, Fax (615) 343-4456</aff></contrib></contrib-group><pub-date pub-type="nihms-submitted"><day>21</day><month>2</month><year>2018</year></pub-date><pub-date pub-type="epub"><day>02</day><month>7</month><year>2018</year></pub-date><pub-date pub-type="collection"><day>02</day><month>7</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>02</day><month>1</month><year>2019</year></pub-date><volume>10</volume><issue>7</issue><elocation-id>a029496</elocation-id><abstract><p id="P1">Development of optimal vaccines for influenza is challenging, in part due to the high antigenic variability in field strains associated with genetic shift from reassortment and genetic drift from point mutations. Discovery of conserved antigenic sites on the hemagglutinin (HA) protein for neutralizing antibodies suggested the possibility that influenza vaccines could be developed that induce focused antibody responses to the conserved neutralizing determinants, especially the HA stem region. Recent studies have focused on the antigenicity and immunogenicity of such domains, using monoclonal antibodies and candidate engineered HA stem-based vaccines. Much progress has been made, but we still do not fully understand the biology of the immune response to this unique antigenic region.</p></abstract></article-meta></front></pmc><affiliations><list></list><tree><noCountry><name sortKey="Crowe, James E" sort="Crowe, James E" uniqKey="Crowe J" first="James E." last="Crowe">James E. Crowe</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Pmc/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000129 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 000129 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Pmc
|étape= Checkpoint
|type= RBID
|clé= PMC:5829045
|texte= Is it possible to develop a 'universal' influenza vaccine?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i -Sk "pubmed:28663208" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a H2N2V1
| This area was generated with Dilib version V0.6.33. |  |